Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
Novartis
Novartis
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Noema Pharma AG
Celgene
Astellas Pharma Inc
Quadriga Biosciences, Inc.
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Takeda
MetVital, Inc.
Novartis